AstraZeneca CEO says Summit's cancer drug will drive next-gen combination treatments
- Summit 近 90 天出现 5 次
- 上一次：同一天稍早 · AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
发生了什么
Pascal Soriot told CNBC that ivonescimab could combine with antibody-drug conjugates to treat tumors that existing immunotherapies handle less well
摘要按规则整理自下方来源原文